Lilly’s Cymbalta approved by European panel
The European Commission has approved Cymbalta, the anxiety drug developed by Eli Lilly and Co. The thumbs-up came from the commission’s European Medicine Agency Committee for Medicinal Products for Human Use, the Indianapolis company said today. The approval opens markets in 27 European Union nations as well as Iceland, Liechtenstein and Norway. Lilly estimates nine […]